DNA 2.0, Inc.
Ex parte reexamination requester·2 ex parte reexams
DNA 2.0, Inc. has requested 2 USPTO ex parte reexaminations. It most often challenges patents owned by GENERAL HOSPITAL CORPORATION, THE. ExamPat indexes the full prosecution record for each proceeding, including office-action grounds, certificate outcomes, and downstream PTAB and Federal Circuit decisions.
Filings by year
Top patent owners challenged
Outcome track record
How this requester's challenges resolve: claims confirmed, amended, mixed, or fully canceled.
- Certificate outcome split across every bucket
- Share of challenges that canceled claims
Challenge metrics
Cancellation rate, average pendency, and the open/closed split across every reexam this requester has filed.
- Outcome rate of closed challenges
- Average pendency in months
Examiners & defense counsel
Which examiners decide this requester's challenges, and which firms defend the targeted patents.
- Most frequent examiners
- Top opposing counsel
Recent reexaminations (2)
| Control # | Filed | Patent | Title | Owner | Status |
|---|---|---|---|---|---|
| 90/012,335 | Jun 22, 2012 | 5,786,464 | OVEREXPRESSION OF MAMMALIAN AND VIRAL PROTEINS | GENERAL HOSPITAL CORPORATION, THE | Closed |
| 90/012,334 | Jun 1, 2012 | 6,114,148 | HIGH LEVEL EXPRESSION OF PROTEINS | GENERAL HOSPITAL CORPORATION, THE | Closed |
See the full reexam picture for DNA 2.0, Inc.
Certificate outcomes, pendency, and the parties and examiners behind these cases. Free to sign up.